U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07524101) titled 'Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD' on April 03.
Brief Summary: The ULTRA-CKD trial is a prospective, randomized, open-label, multicenter trial designed to compare the efficacy and safety of moderate-intensity statin plus ezetimibe combination therapy versus high-intensity statin monotherapy in patients with chronic kidney disease (CKD) and concomitant atherosclerotic cardiovascular disease (ASCVD).
Patients with CKD are at very high risk for ASCVD. In this population, it is important to establish a lipid-lowering strategy that optimizes cardiovascular outcomes while ensuring long-term safety. While high-int...